276 related articles for article (PubMed ID: 22446898)
1. The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels.
Peppone LJ; Rickles AS; Janelsins MC; Insalaco MR; Skinner KA
Ann Surg Oncol; 2012 Aug; 19(8):2590-9. PubMed ID: 22446898
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women.
de Sousa Almeida-Filho B; De Luca Vespoli H; Pessoa EC; Machado M; Nahas-Neto J; Nahas EAP
J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer.
Kim HJ; Lee YM; Ko BS; Lee JW; Yu JH; Son BH; Gong GY; Kim SB; Ahn SH
Ann Surg Oncol; 2011 Jul; 18(7):1830-6. PubMed ID: 21573699
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Serum Vitamin D Levels in Egyptian Females with Breast Cancer.
Ismail A; El-Awady R; Mohamed G; Hussein M; Ramadan SS
Asian Pac J Cancer Prev; 2018 Feb; 19(2):571-576. PubMed ID: 29481024
[TBL] [Abstract][Full Text] [Related]
5. Nutritional risk factors and status of serum 25(OH)D levels in patients with breast cancer: A case control study in India.
Sofi NY; Jain M; Kapil U; Seenu V; Kamal VK; Pandey RM
J Steroid Biochem Mol Biol; 2018 Jan; 175():55-59. PubMed ID: 27687737
[TBL] [Abstract][Full Text] [Related]
6. Low serum 25-hydroxy vitamin D levels are associated with aggressive breast cancer variants and poor prognostic factors in patients with breast carcinoma.
Karthikayan A; Sureshkumar S; Kadambari D; Vijayakumar C
Arch Endocrinol Metab; 2018 Aug; 62(4):452-459. PubMed ID: 30304110
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study.
Buono G; Giuliano M; De Angelis C; Lauria R; Forestieri V; Pensabene M; Bruzzese D; De Placido S; Arpino G
Clin Breast Cancer; 2017 Nov; 17(7):559-563. PubMed ID: 28601383
[TBL] [Abstract][Full Text] [Related]
8. Reproductive factors, nutritional status and serum 25(OH)D levels in women with breast cancer: A case control study.
Sofi NY; Jain M; Kapil U; Seenu V; R L; Yadav CP; Pandey RM; Sareen N
J Steroid Biochem Mol Biol; 2018 Jan; 175():200-204. PubMed ID: 29137944
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study.
Yao S; Sucheston LE; Millen AE; Johnson CS; Trump DL; Nesline MK; Davis W; Hong CC; McCann SE; Hwang H; Kulkarni S; Edge SB; O'Connor TL; Ambrosone CB
PLoS One; 2011 Feb; 6(2):e17251. PubMed ID: 21386992
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum 25 hydroxyvitamin D in breast cancer: An Indian scenario.
Patel SR; Patel KD; Patel KR; Gokani RA; Patel JB; Patel PS; Shah FD
J Steroid Biochem Mol Biol; 2020 Sep; 202():105726. PubMed ID: 32682059
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D Receptor in Breast Cancer Tissues and Its Relation to Estrogen Receptor Alpha (ER-α) Gene Expression and Serum 25-hydroxyvitamin D Levels in Egyptian Breast Cancer Patients: A Case-control Study.
Hemida MA; AbdElmoneim NA; Hewala TI; Rashad MM; Abdaallah S
Clin Breast Cancer; 2019 Jun; 19(3):e407-e414. PubMed ID: 30833174
[TBL] [Abstract][Full Text] [Related]
12. Negative Impact of 25-hydroxyvitamin D Deficiency on Breast Cancer Survival.
Thanasitthichai S; Prasitthipayong A; Boonmark K; Purisa W; Guayraksa K
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3101-3106. PubMed ID: 31653160
[TBL] [Abstract][Full Text] [Related]
13. The relationship between breast cancer treatment, tumour type and vitamin D level in pre- and postmenopausal women.
Streb J; Glanowska I; Streb A; Szpor J; Kryka K; Potocki P; Wójcik M; Jach R
Neuro Endocrinol Lett; 2017 Dec; 38(6):437-440. PubMed ID: 29298285
[TBL] [Abstract][Full Text] [Related]
14. Low pretreatment serum concentration of vitamin D at breast cancer diagnosis in postmenopausal women.
Machado MRM; de Sousa Almeida-Filho B; De Luca Vespoli H; Schmitt EB; Nahas-Neto J; Nahas EAP
Menopause; 2019 Mar; 26(3):293-299. PubMed ID: 30234730
[TBL] [Abstract][Full Text] [Related]
15. The Association of a Breast Cancer Diagnosis With Serum 25-Hydroxyvitamin D Concentration Over Time.
O'Brien KM; Sandler DP; House M; Taylor JA; Weinberg CR
Am J Epidemiol; 2019 Apr; 188(4):637-645. PubMed ID: 30608512
[TBL] [Abstract][Full Text] [Related]
16. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
Cheang MC; Voduc D; Bajdik C; Leung S; McKinney S; Chia SK; Perou CM; Nielsen TO
Clin Cancer Res; 2008 Mar; 14(5):1368-76. PubMed ID: 18316557
[TBL] [Abstract][Full Text] [Related]
17. Serum 25-hydroxyvitamin D deficiency and increased risk of breast cancer among Korean women: a case-control study.
Park S; Lee DH; Jeon JY; Ryu J; Kim S; Kim JY; Park HS; Kim SI; Park BW
Breast Cancer Res Treat; 2015 Jul; 152(1):147-154. PubMed ID: 26037255
[TBL] [Abstract][Full Text] [Related]
18. Association of serum level of 25 hydroxy-vitamin D with prognostic factors for breast cancer.
Kermani IA; Kojidi HT; Gharamaleki JV; Sanaat Z; Ziaei JE; Esfahani A; Seifi S; Ghojazadeh M; Dolatkhah R; Kermani AA; Rad EG
Asian Pac J Cancer Prev; 2011; 12(6):1381-4. PubMed ID: 22126468
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D levels in Mediterranean breast cancer patients compared with those in healthy women.
Pineda-Moncusí M; Garcia-Perez MA; Rial A; Casamayor G; Cos ML; Servitja S; Tusquets I; Diez-Perez A; Cano A; Garcia-Giralt N; Nogues X
Maturitas; 2018 Oct; 116():83-88. PubMed ID: 30244785
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and breast cancer: A systematic review and meta-analysis of observational studies.
Hossain S; Beydoun MA; Beydoun HA; Chen X; Zonderman AB; Wood RJ
Clin Nutr ESPEN; 2019 Apr; 30():170-184. PubMed ID: 30904218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
